Mosley Wealth Management’s AbbVie ABBV Stock Holding History

Mosley Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$601K	Buy	2,120 +176	+9%	+$45.1K	0.17%	94
2026 Q2	$489K	Sell	1,944 -419	-18%	-$90.1K	0.16%	98
2026 Q1	$547K	Sell	2,363 -1	-0%	-$222	0.25%	83
2025 Q4	$547K	Buy	+2,364	New	+$539K	0.25%	91
2024 Q4	$343K	Sell	1,957 -2,031	-51%	-$373K	0.21%	91
2024 Q3	$744K	Buy	3,988 +253	+7%	+$47.2K	0.51%	42
2024 Q2	$641K	Sell	3,735 -93	-2%	-$15.4K	0.55%	39
2024 Q1	$697K	Sell	3,828 -78	-2%	-$13.4K	0.65%	34
2023 Q4	$605K	Buy	+3,906	New	+$569K	0.6%	36

Other funds holding ABBV

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return

Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Boston Partners Boston, Massachusetts $111B AUM 30.48% 1-Year Est. Return

Mosley Wealth Management's ABBV Position: Q3 2026 in Review

Mosley Wealth Management increased its AbbVie (ABBV) stake by 9.1% in Q3 2026, buying an estimated $45.1K and bringing the position to 2,120 shares worth $601K. The position accounts for 0.17% of the portfolio, ranked #94.

Mosley Wealth Management first reported a position in ABBV in Q4 2023 and has held it in 9 quarters since. The position peaked at $744K in Q3 2024. 3,064 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

Mosley Wealth Management held 2,120 shares of AbbVie worth $601K as of Q3 2026.
Mosley Wealth Management bought 176 AbbVie shares in Q3 2026, an estimated $45.1K.
AbbVie made up 0.17% of Mosley Wealth Management's portfolio in Q3 2026, its #94 holding.
Mosley Wealth Management first reported a position in AbbVie in Q4 2023 and has held it in 9 quarters since.
Mosley Wealth Management's AbbVie position peaked at $744K in Q3 2024.
3,064 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Mosley Wealth Management's 13F filing for Q3 2026, filed 16 Oct 2026.